Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84.02	124.29	143.74	151.79	280.12
Short-Term Investments	470.5	657.04	606.35	847.12	677.95
Cash & Short-Term Investments	554.52	781.32	750.09	998.92	958.07
Cash Growth	-29.03%	4.16%	-24.91%	4.26%	41.30%
Receivables	-	-	-	5.22	4.94
Prepaid Expenses	17.79	17.35	16.7	12.11	11.47
Other Current Assets	5.97	10.53	3.32	3.26	1.76
Total Current Assets	578.28	809.2	770.1	1,020	976.24
Property, Plant & Equipment	41.72	57.67	68.87	75.39	27.32
Other Intangible Assets	-	2.3	2.3	2.3	2.3
Other Long-Term Assets	1.34	2.12	2.71	2.58	2.58
Total Assets	621.33	871.3	843.98	1,100	1,008
Accounts Payable	7.71	14.1	9.21	10.58	8.28
Accrued Expenses	13.65	21.24	14.89	22.7	13.56
Current Portion of Leases	3.77	5.73	4.96	4.28	1.84
Current Unearned Revenue	-	7.68	-	-	0.25
Other Current Liabilities	0.46	1.99	1.2	26.15	0.4
Total Current Liabilities	25.58	50.73	30.27	63.71	24.32
Long-Term Leases	28.69	42.78	48.5	53.47	21.06
Other Long-Term Liabilities	-	-	13.21	32.38	65.26
Total Liabilities	54.27	93.5	91.98	149.55	110.64
Common Stock	0.17	0.17	0.13	0.12	0.11
Additional Paid-In Capital	2,581	2,517	2,153	2,019	1,667
Retained Earnings	-2,015	-1,738	-1,401	-1,059	-768.1
Comprehensive Income & Other	0.73	-0.99	-0.2	-10.42	-1.09
Total Common Equity	567.06	777.79	752	950.22	897.81
Shareholders' Equity	567.06	777.79	752	950.22	897.81
Total Liabilities & Equity	621.33	871.3	843.98	1,100	1,008
Total Debt	32.46	48.5	53.47	57.74	22.9
Net Cash (Debt)	522.06	732.82	696.62	941.18	935.17
Net Cash Growth	-28.76%	5.20%	-25.98%	0.64%	43.07%
Net Cash Per Share	3.04	5.13	5.68	8.39	9.83
Filing Date Shares Outstanding	178.73	169.52	131.18	121.38	108.28
Total Common Shares Outstanding	173.87	167.76	127.46	121.11	108.21
Working Capital	552.7	758.48	739.83	955.8	951.92
Book Value Per Share	3.26	4.64	5.90	7.85	8.30
Tangible Book Value	567.06	775.49	749.7	947.92	895.51
Tangible Book Value Per Share	3.26	4.62	5.88	7.83	8.28
Machinery	22.37	30.93	29.08	24.98	17.88
Construction In Progress	-	0.07	1.58	1.22	0.13
Leasehold Improvements	0.91	3.83	3.83	3.83	2.9

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q